These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12521085)

  • 1. Role of fibronectin in diagnosis of malignant ascites.
    Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
    J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
    Rana SV; Babu SG; Kocchar R
    Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascitic fluid cholesterol in malignant and tubercular ascites.
    Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
    J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of polyamine assay in diagnosis of malignant ascites].
    Peng A; Zhao S; Zhang X; Zhang G
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):59-62, 65. PubMed ID: 9868032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
    Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
    Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
    Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
    Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
    Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
    Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
    Khan FY
    Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers of the tumor origin of ascites].
    Romette J; di Costanzo-Dufetel J
    Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of fibronectin as a marker of malignant ascites.
    Siddiqui RA; Kochhar R; Singh V; Rajwanshi A; Goenka MK; Mehta SK
    J Gastroenterol Hepatol; 1992; 7(2):161-4. PubMed ID: 1571498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascitic fluid cholesterol in differential diagnosis of ascites.
    Garg R; Sood A; Arora S; Bhatia KL; Chawla AS; Gupta R; Chawla LS
    J Assoc Physicians India; 1993 Oct; 41(10):644-6. PubMed ID: 8294324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.
    Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL
    NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibronectin in the ascitic fluid: its diagnostic significance].
    Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
    Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
    Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
    Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of fibronectin concentration in benign and malignant ascites.
    Adamsen S; Jönsson P; Brodin B; Lindberg B; Jorpes P
    Eur J Surg; 1991 May; 157(5):325-8. PubMed ID: 1678645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
    Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
    Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The validity of the proteins concentrations in the ascitic liquid and serum for the differential diagnosis of the ascitis].
    Valdivia R M; Llanos C A; Zapata S C; Muñoz O N
    Rev Gastroenterol Peru; 2002; 22(4):279-86. PubMed ID: 12525843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The analysis of ascitic fluid].
    González Maldonado JJ
    Rev Gastroenterol Mex; 1993; 58(2):170-2. PubMed ID: 7747028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites.
    Dwivedi M; Misra SP; Misra V; Kumar R
    Am J Gastroenterol; 1990 Sep; 85(9):1123-5. PubMed ID: 2389724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.